CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
CSPG4 CAR 重定向的细胞因子诱导杀伤淋巴细胞 (CIK) 作为一种有效的 HLA I 类缺陷型黑色素瘤细胞免疫疗法
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-023-02884-x.
Lidia Giraudo #,Giulia Cattaneo #,Loretta Gammaitoni,Ilenia Iaia,Chiara Donini,Annamaria Massa,Maria Laura Centomo,Marco Basiricò,Elisa Vigna,Alberto Pisacane,Franco Picciotto,Enrico Berrino,Caterina Marchiò,Alessandra Merlini,Luca Paruzzo,Stefano Poletto,Daniela Caravelli,Andrea Michela Biolato,Valentina Bortolot,Elisa Landoni,Marco Ventin,Cristina R Ferrone,Massimo Aglietta,Gianpietro Dotti,Valeria Leuci,Fabrizio Carnevale-Schianca #,Dario Sangiolo #